Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Grasping the Elements of Medical caretaker Pay rates: Factors That Shape Your Pay - 2James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- 3Vote in favor of the bloom plan that adds a bit of excellence to your life!
- 4Your kid wants it now. What saying yes, no or not yet teaches kids about money and instant gratification.
- 5Vote in favor of the handheld vacuum that you love for its strong attractions!
- The most effective method to Guarantee Scholastic Honesty in Web-based Degrees
- NASA's Artemis II launch leaves Americans in awe: 'We're going back to the frickin' moon!'
- East Germany Somehow Built a Real Sports Car and It Was Wild
- Opening Potential: Self-awareness and Long lasting Learning
- This Canadian crater looks like marbled meat | Space photo of the day for Jan. 6, 2026
- Hanwha Ocean secures orders worth $866m for five vessels
- 6 Solid Vehicle Fix Administrations to Keep Your Vehicle in Prime Condition
- Holden Commodore Turbo BT1 Police Interceptor Offered for Sale in Australia
- Anthony Joshua's driver charged over Nigeria crash that killed two
